Product Images Divalproex Sodium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Divalproex Sodium NDC 0832-7123 by Upsher-smith Laboratories, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - divalproex 01

Chemical Structure - divalproex 01

Figure 1 - divalproex 02

Figure 1 - divalproex 02

This is a table showing percentages and some codes for studies 1 and 2, along with the YMRS and MRS rating scales. Specific details about the studies or what the codes represent are not available.*

Figure 2 - divalproex 03

Figure 2 - divalproex 03

The text describes a chart showing the % Reduction in CPS (likely meaning "cycles per second") Rate for patients taking either Divalproex sodium or Placebo. The chart shows a range of percentages from -50% to 100% reduction, with the majority of patients in the 0-50% range. The chart also shows the percentage of patients who saw improvement, no change, or worsening in their condition.*

Figure 3 - divalproex 04

Figure 3 - divalproex 04

This document appears to be a chart displaying the percentage reduction in CPS (central pain syndrome) rate categorized by high and low dose. It also indicates the percentage of patients and the level of improvement or worsening.*

Figure 4 - divalproex 05

Figure 4 - divalproex 05

This appears to be a list of names related to some medical study or research. More context is required to provide a useful description.*

PRINCIPAL DISPLAY PANEL - 125 mg Tablet Bottle Label - divalproex 06

PRINCIPAL DISPLAY PANEL - 125 mg Tablet Bottle Label - divalproex 06

Diettgey is a delayed-release tablet that contains 125mg of valproic acid activity. These tablets are children resistant, and should be stored at a temperature between 20-25°C. Each tablet contains divaproex sodium equivalent to valproic acid. It is recommended to swallow tablets whole and not to chew or crush them. The package is manufactured by Upsher-smith laboratories, LLC in Maple Grove, MN55369.*

PRINCIPAL DISPLAY PANEL - 250 mg Tablet Bottle Label - divalproex 07

PRINCIPAL DISPLAY PANEL - 250 mg Tablet Bottle Label - divalproex 07

DAETTGEY @ Delayed-Release Tablets, USP 250 mg is a drug used for Valproic Acid Activity, containing 100 tablets which are available only on prescription. Each tablet has Divaproex Sodium equivalent to valproic acid of 250mg. The usual dosage is specified on the package which is a child-resistant container and should be stored in a cool dry place. These tablets should not be crushed and should be kept out of reach of children. Manufactured by PSHER-SMITH LABORATORIES, LLC in Minnesota. Unfortunately, no additional information was displayed.*

PRINCIPAL DISPLAY PANEL - 500 mg Tablet Bottle Label - divalproex 08

PRINCIPAL DISPLAY PANEL - 500 mg Tablet Bottle Label - divalproex 08

This is a description for medication tablets containing 500mg of delayed-release valproic acid, used for the treatment of seizures and bipolar disorder. The package contains 100 tablets and should be stored at controlled room temperature. The tablets should be swallowed whole and stored in a child-resistant container. The medication should only be dispensed with a prescription and the package insert should be consulted for full prescribing information. The manufacturer is Upsher-Smith Laboratories.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.